Transforming growth factor-beta1 induces activation of Ras, Raf-1, MEK and MAPK in rat hepatic stellate cells

Area of Science:

• Cell biology
• Molecular signaling
• Hepatology

Background:

• Hepatic stellate cells (HSCs) transdifferentiate into myofibroblast-like cells, a key event in liver fibrosis.
• This transdifferentiation and subsequent proliferation are regulated by transforming growth factor-beta1 (TGF-β1).
• The intracellular signaling pathways mediating TGF-β1's effects in HSCs remain largely uncharacterized.

Purpose of the Study:

• To investigate the intracellular signal transducers activated by TGF-β1 in cultured hepatic stellate cells.
• To elucidate the role of specific signaling molecules in TGF-β1-induced HSC activation and proliferation.
• To determine if autocrine loops involving basic fibroblast growth factor (bFGF) or platelet-derived growth factor (PDGF) mediate TGF-β1 effects.

Main Methods:

• Primary hepatic stellate cells were cultured.
• Cells were treated with TGF-β1.
• Activation of signaling proteins including Ras, Raf-1, MEK, and MAPK (p42 and p44) was assessed.
• Experiments were conducted to rule out mediation by bFGF or PDGF autocrine loops.

Main Results:

• TGF-β1 treatment induced the activation of Ras, Raf-1, MEK, and MAPK (p42 and p44) in cultured hepatic stellate cells.
• The activation of MAPK was dependent on the prior activation of MEK.
• The observed signaling events were not mediated by autocrine loops of bFGF or PDGF.

Conclusions:

• TGF-β1 activates the Ras/Raf-1/MEK/MAPK signaling pathway in hepatic stellate cells.
• MEK acts as a crucial upstream activator of MAPK in this TGF-β1-induced signaling cascade.
• These findings identify key intracellular mediators of TGF-β1 signaling in HSCs, independent of bFGF or PDGF autocrine loops.